JAN 20, 2019 04:13 PM PST

Multiple sclerosis treatments hold long-term benefits

WRITTEN BY: Nouran Amin

An international study, led by the Clinical Outcomes Research unit (CORe) at Royal Melbourne Hospital and University of Melbourne, concludes the importance of early treatments of multiple sclerosis (particularly within the first five years of onset) holds extensive long-term benefits.

Learn more about Multiple Sclerosis (MS):

The study was the first to provide evidence that current drug treatments delay the progression of multiple sclerosis (MS) into its secondary stage which is described by an ongoing increase of disability involving the worsening of physical and mental capacity as well as the reduced quality of life. The crucial need to delay the progression represents an important outcome for individuals living with multiple sclerosis.

The research generated data from 1555 patients at 68 neurological clinics across 21 countries and highlighted the importance to treat MS pro-actively.

Multiple sclerosis is a condition characterized by areas of damage on the brain. This damage affects the covering that protects nerves (the myelin sheath).

Credit: NIH Genetics Home Reference

"People who converted from relapsing MS to secondary progressive MS experience gradual and mostly irreversible worsening of disability,” said Associate Professor and head of the MS Service at The Royal Melbourne Hospital and CORe at the University of Melbourne, Tomas Kalincik."Most of the therapies that we use to treat MS have no effect once people have converted to secondary progressive MS. This study shows us how important it is to treat relapsing MS early and pro-actively," Associate Professor Kalincik said.

Results of the study, in collaboration with the University of Cambridge, were published in the international medical journal, JAMA. Associate Professor Kalincik believes that the results are reassuring neurologists and patients with MS. He states, "This study shows that the therapies they have been treated with for many years, significantly improve the quality of their lives over the long-term.”

Source: The Royal Melbourne Hospital

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 20, 2019
Cell & Molecular Biology
NOV 20, 2019
How the Kava Plant Creates Medicinal Compounds
Nature has given us some of our best medicines; it's thought that as many as half the drugs we used are derived from natural products....
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Insulin Drug Could Treat Glioblastoma
A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold...
NOV 20, 2019
Technology
NOV 20, 2019
Biomagents for Drug Discovery
Scientists have recently developed a chip-like device that utilizes tiny magnets that sort large populations of mixed cell types. "We casually agreed...
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Diabetes: The next-generation therapy
A publication in Nature Communications describes a therapeutic that can avoid the side-effects of insulin in diabetic treatments particularly hypoglycemia....
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Advancing Nanocontainers for Drug Delivery
Nanocontainers work by delivering drugs to a localized region in the body, many chemotherapeutics work in that matter. The high specificity of this drug de...
NOV 20, 2019
Cancer
NOV 20, 2019
C2 combination targets cancer cells more efficiently
Treating cancer is in part so difficult because to be effective, high doses of aggressive drugs must be administered to patients. These treatments often ha...
Loading Comments...